Human immunodeficiency virus infection and female lower genital tract malignancy.
The risk of lower genital tract neoplasia is increased in women infected with HIV. This has been best demonstrated in cervical squamous intraepithelial lesions, but has also been observed in vulvar and perianal intraepithelial lesions in some studies. Alterations in the prevalence and natural history of human papillomavirus infections of the lower genital tract appear to account for much of the increase. HIV-infected women are approximately four times more likely to be infected with human papillomavirus (including infection with high oncogenic risk human papillomavirus types) than are HIV-uninfected women, and these infections are more likely to be persistent. Human papilomavirus-associated lesions may be more difficult to treat in HIV-infected women. These data highlight the need to develop effective cervical cancer prevention programs for HIV-infected women.
Kuhn
L
L
Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA.
Sun
X W
XW
Wright
T C
TC
D001005:Anus Neoplasms / Q000150:complications / Q000453:epidemiology; D002278:Carcinoma in Situ / Q000150:complications / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D014412:Tumor Virus Infections / Q000150:complications / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000150:complications* / Q000453:epidemiology / Q000517:prevention & control; D014846:Vulvar Neoplasms / Q000150:complications / Q000453:epidemiology; D002578:Uterine Cervical Dysplasia / Q000150:complications* / Q000453:epidemiology / Q000517:prevention & control